Morbidity after induction therapy and surgery in non small cell lung cancer (NSCLC). Focus on pulmonary function

Lung Cancer. 2002 May;36(2):219-20. doi: 10.1016/s0169-5002(01)00473-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Humans
  • Lung Neoplasms / mortality
  • Lung Neoplasms / surgery
  • Lung Neoplasms / therapy*
  • Morbidity
  • Radiotherapy Dosage
  • Remission Induction
  • Respiratory Function Tests